Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jason J. Lavinder"'
Autor:
Lori A. Rowe, Ilya J. Finkelstein, Kamyab Javanmardi, Daniel R. Boutz, Jin Eyun Kim, Shivaprakash Gangappa, Jonathan R. McDaniel, Ralph S. Baric, Dhwani Batra, Maria D. Person, George Georgiou, William N. Voss, Brent L. Iverson, Gregory C. Ippolito, Katia George, Andrew S. Herbert, Yuri Tanno, Foteini Bartzoka, Shawn A. Abbasi, Jason S. McLellan, Jimmy Gollihar, Suryaprakash Sambhara, Daniel Billick, Jule Goike, Chelsea J. Paresi, Whitney Pickens, George Delidakis, Justin S. Lee, Nicole V. Johnson, Yixuan J. Hou, Nianshuang Wang, Andrew P. Horton, Jason J. Lavinder, Jan Pohl, Michelle Gadush, Chia Wei Chou, John M. Dye, Dalton M Towers
Publikováno v:
bioRxiv
Although humoral immunity is essential for control of SARS-CoV-2, the molecular composition, binding epitopes and effector functions of the immunoglobulin G (IgG) antibodies that circulate in blood plasma following infection are unknown. Proteomic de
Autor:
Jason J. Lavinder, Gregory C. Ippolito
Publikováno v:
Nature Immunology. 23:8-10
Autor:
Katherine K. Perez, Randall J. Olsen, Jian Chen, Eric Salazar, John Rogers, S. Wesley Long, Jimmy Gollihar, Matthew Ojeda Saavedra, Bevin Valdez Lopez, Brian Castillo, Ahmed Shehabeldin, Andre C. Maranhao, David Joseph, Todd N. Eagar, Cheryl Chavez-East, Paul A. Christensen, David W. Bernard, Christina Talley, Christopher Leveque, Karen D. Thomas, Monisha Dey, Concepcion C. Cantu, Madiha Ashraf, Faisal Masud, Katharine G. Dlouhy, Taryn A Eubank, Prasanti Yerramilli, Curt Hampton, Sishir Subedi, Jason J. Lavinder, Layne Pruitt, James M. Musser, Gregory C. Ippolito, Mary R. Schwartz, Guy Williams
Publikováno v:
The American Journal of Pathology
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma therapy has been used with varying degrees of success to treat severe mic
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e101322 (2014)
Rabbits have been used extensively as a model system for the elucidation of the mechanism of immunoglobulin diversification and for the production of antibodies. We employed Next Generation Sequencing to analyze Ig germline V and J gene usage, CDR3 l
Externí odkaz:
https://doaj.org/article/76332593ea79403cbd31aaacfd128991
Autor:
Zivko L. Nikolov, Jimmy Gollihar, Ching-Lin Hsieh, Ilya J. Finkelstein, Elizabeth C Gardner, Andrew P. Horton, Thomas H. Segall-Shapiro, Laura Soto-Sierra, Andre C. Maranhao, Kamyab Javanmardi, Gejji, William N. Voss, Abhinay Gontu, Ruth H. Nissly, Ankur Annapareddy, Michelle Byrom, John M. Dye, Andrew S. Herbert, Foteini Bartzoka, Andrew D. Ellington, Daniel R. Boutz, Anna Battenhouse, Nianshuang Wang, Cardona Ja, Kapur, Jule Goike, Gregory C. Ippolito, Johanson Mj, Susan L. Woodard, Jason J. Lavinder, Abbassi S, Foster Er, James M. Musser, Jason S. McLellan, George Georgiou, Edward M. Marcotte, Zhou L, Suresh V. Kuchipudi, Rebecca L. Renberg, R. A. Hughes
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 2
article-version (status) pre
article-version (number) 2
The ongoing evolution of SARS-CoV-2 into more easily transmissible and infectious variants has sparked concern over the continued effectiveness of existing therapeutic antibodies and vaccines. Hence, together with increased genomic surveillance, meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::345d56439a31016a754b4a05c08edae5
https://doi.org/10.1101/2021.04.07.438849
https://doi.org/10.1101/2021.04.07.438849
Autor:
John Ludes-Meyers, Daniel Wrapp, Ilya J. Finkelstein, Jason S. McLellan, Patrick O. Byrne, Jennifer A. Maynard, Christy K. Hjorth, Jory A. Goldsmith, Ching-Lin Hsieh, Hung-Che Kuo, Kevin C. Le, Gregory C. Ippolito, Andrea M. DiVenere, Chia Wei Chou, Annalee W. Nguyen, Jeffrey M. Schaub, Nianshuang Wang, Kamyab Javanmardi, Nicole V. Johnson, Jason J. Lavinder
Publikováno v:
Nat Protoc
The severe acute respiratory syndrome coronavirus 2 spike protein is a critical component of coronavirus disease 2019 vaccines and diagnostics and is also a therapeutic target. However, the spike protein is difficult to produce recombinantly because
Autor:
Yixuan J. Hou, Daniel Billick, Shivaprakash Gangappa, Jason S. McLellan, Lori A. Rowe, Jonathan R. McDaniel, Brent L. Iverson, Dhwani Batra, Chelsea J. Paresi, Nicole V. Johnson, Shawn A. Abbasi, Michelle Gadush, Andrew S. Herbert, Jimmy Gollihar, Ralph S. Baric, Gregory C. Ippolito, Foteini Bartzoka, Andrew P. Horton, George Georgiou, William N. Voss, Yuri Tanno, Jan Pohl, George Delidakis, John M. Dye, Whitney Pickens, Dalton M Towers, Suryaprakash Sambhara, Justin S. Lee, Nianshuang Wang, Jason J. Lavinder, Jule Goike, Daniel R. Boutz, Jin Eyun Kim, Katia George, Maria D. Person
Publikováno v:
Science (New York, N.y.)
SUMMARYAlthough humoral immunity is essential for control of SARS-CoV-2, the molecular composition, binding epitopes and effector functions of the immunoglobulin G (IgG) antibodies that circulate in blood plasma following infection are unknown. Prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a594216b5cb4ab9e788a3418165d91b2
https://doi.org/10.1101/2020.12.20.423708
https://doi.org/10.1101/2020.12.20.423708
Autor:
Jimmy Gollihar, David Bernard, Vivek Kapur, Abhinay Gontu, Gregory C. Ippolito, Sreenidhi Srinivasan, Randall M. Rossi, Indira Poojary, Laura I. Prugar, Randall J. Olsen, Eric Salazar, Peter J. Hudson, Jose A. Cardona, James M. Musser, Ian M. Bird, Zhicheng Jin, Nicole M. Josleyn, Todd N. Eagar, Denver Greenawalt, Picheng Zhao, Kathleen E. Huie, John M. Dye, Dalton M Towers, Suresh V. Kuchipudi, Jian Chen, Andrew S. Herbert, Christopher Leveque, Xin Yi, Isabella M. Cattadori, Ruth H. Nissly, Brian Castillo, Jason J. Lavinder, S. Wesley Long, Paul A. Christensen
Publikováno v:
J Clin Invest
bioRxiv
article-version (status) pre
article-version (number) 1
bioRxiv
article-version (status) pre
article-version (number) 1
Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that detect levels of neutralizing antibodies that may be protective. We studied the relationship between anti-spike ectodomain (ECD) and anti-receptor binding domain (RB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22021f76c75c2351c162e981d74ff6a8
https://europepmc.org/articles/PMC7685744/
https://europepmc.org/articles/PMC7685744/
Autor:
Hampton C, Chavez-East C, Todd N. Eagar, Prasanti Yerramilli, John Rogers, Taryn A Eubank, Gregory C. Ippolito, Layne Pruitt, Dey M, James M. Musser, Concepcion C. Cantu, David Joseph, Mary R. Schwartz, Andre C. Maranhao, Randall J. Olsen, Paul A. Christensen, David W. Bernard, Christopher Leveque, Brian Castillo, Eric Salazar, Faisal Masud, Scott Wesley Long, Talley C, Matthew Ojeda Saavedra, Williams G, Ahmed Shehabeldin, Madiha Ashraf, Karen D. Thomas, Bevin Valdez Lopez, Jian Chen, Katharine G. Dlouhy, Sishir Subedi, Jason J. Lavinder, Katherine K. Perez, Jimmy Gollihar
Publikováno v:
medRxiv
BackgroundCOVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent plasma therapy has been used with varying degrees of success to treat severe
Autor:
Ruth H. Nissly, Laura I. Prugar, Peter J. Hudson, Eric Salazar, Nicole Joselyn, S. Wesley Long, Abinhay Gontu, Picheng Zhao, José Rubén Parra Cardona, Vivek Kapur, Suresh V. Kuchipudi, Zhicheng Jin, Denver Greenawalt, Sreenidhi Srinivasan, David W. Bernard, Randall M. Rossi, Randall J. Olsen, Jason J. Lavinder, Indira Poojary, Ian M. Bird, Andrew S. Herbert, Xin Yi, Isabella M. Cattadori, Gregory C. Ippolito, John M. Dye, Dalton M Towers, Brian Castillo, James M. Musser, Jian Chen, Paul A. Christensen, Jimmy Gollihar, Kathleen E. Huie, Todd N. Eagar, Christopher Leveque
Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that detect levels of neutralizing antibodies that may be protective. We studied the relationship between anti-spike ectodomain (ECD) and anti-receptor binding domain (RB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aa5962ab22ea3bd35b642d894fb2cca
https://doi.org/10.1101/2020.06.08.138990
https://doi.org/10.1101/2020.06.08.138990